Anthropic
Similar to conventional biotechnology operators, Anthropic is turning toward laboratory automation. People familiar with the initiative stated that the firm wants to evaluate how its Claude models can guide robotic hardware to run physical bench tests with minimal human supervision. A company spokesperson maintained that human oversight remains critical to enforce safety protocols across all facilities.
The company built the “wet lab”, a workspace tailored for conducting physical biological experiments, to advance past purely computational “in silico” screening, according to a report by news agency Reuters. Anthropic has established a biology facility in the San Francisco Bay Area, extending its AI efforts straight into living laboratory science just days after its top leadership urged the tech industry to cool the pace of frontier model development. Citing insiders familiar with the initiative, the report noted that while the startup aims to uncover breakthrough therapies for neglected rare illnesses, the move comes during a period of intense public anxiety over the technological disruption. Anthropic’s head of life sciences, Eric Kauderer-Abrams, verified the lab and day-to-day operation of the physical laboratory. The physical lab marks an initial milestone in Anthropic’s broader goal to tackle health conditions that mainstream pharmaceutical giants are unable to. An insider pointed out that the company hopes to demonstrate real-world healthcare breakthroughs before skepticism grows over widespread workforce displacement or theoretical safety dangers.